5-[3-(2,5-DICHLORO-4,6-DIMETHYL-1-OXY-PYRIDIN-3-YL)-[1,2,4]OXADIAZOL-5-YL]-2-HYDROXY-3-METHOXY-1-NITROBENZENE AS AN INTERMEDIATE TO PREPARE A CATECHOL-O-METHYLTRANSFERASE INHIBITOR

There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate. (see formula I) L'invention concerne un intermédi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEARMONTH, DAVID ALEXANDER, REITER, KLAUS, SCHLUMMER, BJOERN, ZIMMERMANN, AXEL, KISS, LASZLO ERNO, RUSSO, DOMENICO, WAHNON, JORGE BRUNO REIS, ESZENYI, TIBOR, KREIS, MICHAEL
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate. (see formula I) L'invention concerne un intermédiaire méthylé qui peut être déméthylé pour fournir un inhibiteur de la catéchol-O-méthyltransférase utile dans le traitement de la maladie de Parkinson. L'invention concerne également des procédés de fabrication et d'utilisation dudit intermédiaire.